Three Rutgers University researchers seek to address important gaps in understanding not only the cognitive, neural, and immunological consequences of COVID-19 in older African Americans but also how those consequences can impact this population’s risk for Alzheimer’s Disease.
Rutgers scientists have developed a lab test that can quickly and easily identify which variant of the virus causing COVID-19 has infected a person, an advance expected to greatly assist health officials tracking the disease and physicians treating infected patients.
According to groundbreaking research from Rutgers University–Camden, South Jersey families receiving assistance from the Whole Families Approach, a program that pools social-service providers together in an effort to offer improved support, have experienced better outcomes than non-participants.
A rapid test that detects all known COVID-19 variants, including the highly transmissible Omicron variant, has been developed by researchers at Rutgers New Jersey Medical School.
A Rutgers study gives new insight into the experiences and perspectives of Black and Latinx people working in supportive health care roles during the COVID-19 pandemic.
Rutgers Robert Wood Johnson Medical School (RWJMS) is projected to receive approximately $30 million, establishing a critical partnership with the larger National Institutes of Health-funded RECOVER initiative to study long-term and delayed impacts of COVID-19 in children and lead a national collaboration with the potential to recruit from any state to investigate these outcomes.
Nearly 1 in 5 people in the United States over the age of 12 haven’t gotten at least one shot. Some may be reluctant to take a vaccine they believe has only been tested for a few months, but that couldn’t be further from the truth, says Michelle Carlin, an assistant professor of forensic chemistry at Rutgers University–Camden.